Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Graft-versus-Host Disease

Quality of life associated with acute and chronic graft-versus-host disease

Bone Marrow Transplantation volume 38, pages 305–310 (2006)Cite this article

Abstract

Acute and chronic graft-versus-host diseases (GVHD) are associated with increased morbidity and mortality after hematopoietic stem cell transplantation (HCT). We prospectively measured the quality of life (QOL) of patients undergoing allogeneic transplantation. Ninety-six subjects completed self-assessment surveys before HCT, and at 6 and/or 12 months post-HCT that included the Medical Outcomes Study Short Form 12 (SF12) and the Functional Assessment of Cancer Therapy-Bone Marrow Transplant scale. Eighty-three percent of survivors responded at 6 and 12 months. Physical and mental functioning assessed by the SF12 was not associated with either acute or chronic GVHD. In contrast, the trial outcome index (TOI) of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant was sensitive to occurrence of either acute or chronic GVHD. GVHD is a major determinant of the long-term QOL of survivors. The adverse effects of acute GVHD are detectable with the TOI at 6 months post transplantation after which development of chronic GVHD is the most strongly correlated with worse QOL.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Lee SJ, Vogelsang G, Flowers MED . Chronic graft versus host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  Google Scholar 

  2. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14–21.

    Article  CAS  Google Scholar 

  3. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406–414.

    Article  CAS  Google Scholar 

  4. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898–1906.

    Article  CAS  Google Scholar 

  5. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.

    Article  CAS  Google Scholar 

  6. Duell T, van Lint MT, Ljungman P, Tichelli A, Socie G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.

    Article  CAS  Google Scholar 

  7. Ochs LA, Miller WJ, Filipovich AH, Haake RJ, McGlave PB, Blazar BR et al. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 1994; 13: 455–460.

    CAS  Google Scholar 

  8. Alyea EP, Weller E, Fisher DC, Freedman AS, Gribben JG, Lee S et al. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2002; 8: 601–607.

    Article  Google Scholar 

  9. Antin JH, Kim HT, Cutler C, Ho VT, Lee SJ, Miklos DB et al. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood 2003; 102: 1601–1605.

    Article  CAS  Google Scholar 

  10. Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ et al. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 328–336.

    Article  CAS  Google Scholar 

  11. Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005; 105: 1810–1814.

    Article  CAS  Google Scholar 

  12. Ho VT, Kim HT, Li S, Hochberg EP, Cutler C, Lee SJ et al. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease. Bone Marrow Transplant 2004; 34: 987–994.

    Article  CAS  Google Scholar 

  13. Ware Jr J, Kosinski M, Keller SD . A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.

    Article  Google Scholar 

  14. Cella D . Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Northwestern University: Evanston, 1997 November 1997.

    Google Scholar 

  15. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.

    Article  CAS  Google Scholar 

  16. McQuellon RP, Russell GB, Rambo TD, Craven BL, Radford J, Perry JJ et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 1998; 21: 477–486.

    Article  CAS  Google Scholar 

  17. Lee S, Cook EF, Soiffer R, Antin JH . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444–452.

    Article  Google Scholar 

  18. Cella D, Eton DT, Fairclough DL, Bonomi P, Heyes AE, Silberman C et al. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol 2002; 55: 285–295.

    Article  Google Scholar 

  19. Lee SJ, Cook EF, Soiffer RJ, Antin JH . Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8: 444–452.

    Article  Google Scholar 

  20. Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 1994; 13: 589–596.

    CAS  Google Scholar 

  21. Marks DI, Gale DJ, Vedhara K, Bird JM . A quality of life study in 20 adult long-term survivors of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1999; 24: 191–195.

    Article  CAS  Google Scholar 

  22. Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614–619.

    Article  CAS  Google Scholar 

  23. Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T . Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.

    Article  CAS  Google Scholar 

  24. Socie G, Mary JY, Esperou H, Robert DV, Aractingi S, Ribaud P et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2001; 113: 194–201.

    Article  CAS  Google Scholar 

  25. Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA . Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002; 20: 2334–2343.

    Article  CAS  Google Scholar 

  26. Andrykowski MA, Greiner CB, Altmaier EM, Burish TG, Antin JH, Gingrich R et al. Quality of life following bone marrow transplantation: findings from a multicentre study. Br J Cancer 1995; 71: 1322–1329.

    Article  CAS  Google Scholar 

  27. Prieto JM, Saez R, Carreras E, Atala J, Sierra J, Rovira M et al. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1133–1142.

    CAS  Google Scholar 

  28. Molassiotis A, van den Akker OB, Milligan DW, Goldman JM, Boughton BJ, Holmes JA et al. Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 1996; 17: 249–258.

    CAS  Google Scholar 

  29. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the patients who participated in this study. This work was funded in part by P01 HL070149 from the National Heart, Lung and Blood Institute and the Amy Strelzer-Manasevit Scholars Award.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

    S J Lee, V T Ho, C Cutler, E P Alyea, R J Soiffer & J H Antin

  2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA

    H T Kim

Authors
  1. S J Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H T Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V T Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Cutler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E P Alyea
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R J Soiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J H Antin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S J Lee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, S., Kim, H., Ho, V. et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 38, 305–310 (2006). https://doi.org/10.1038/sj.bmt.1705434

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705434

Keywords

  • quality of life
  • acute graft-versus-host disease
  • chronic graft-versus-host disease
  • stem cell transplantation

This article is cited by

Search

Advanced search

Quick links